News from viacyte, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 20, 2022, 08:00 ET ViaCyte to Participate in 2022 Advanced Technologies & Treatments for Diabetes Conference

Manasi Sinha Jaiman, M.D., M.P.H., who was recently appointed Chief Medical Officer at ViaCyte, Inc., a clinical-stage cellular therapy company with...

Jan 19, 2022, 08:00 ET ViaCyte Strengthens Management Team with Appointment of Alyssa Levin as Chief Financial Officer and Addition of Lisa Porter, MD, to the Board of Directors

ViaCyte, Inc., a clinical-stage regenerative medicine company developing novel cell replacement therapies to address diseases with significant unmet...

Dec 03, 2021, 08:00 ET ViaCyte Chief Scientific Officer to Deliver Keynote Address at JDRF Mission Summit

ViaCyte, Inc., a clinical-stage regenerative medicine company focused on developing novel cell replacement therapies to address diseases with...

Dec 02, 2021, 11:05 ET ViaCyte's Stem Cell-Derived Treatment for Type 1 Diabetes Shows Promising Results in Two Published Studies

ViaCyte, Inc., a clinical-stage regenerative medicine company focused on developing novel cell replacement therapies to address diseases with...

Nov 30, 2021, 08:00 ET ViaCyte Appoints Marty Lorenzo as General Counsel

ViaCyte, Inc., a clinical-stage regenerative medicine company developing novel cell replacement therapies to address diseases with significant unmet...

Oct 20, 2021, 08:00 ET ViaCyte to Present at the Jefferies Gene Therapy/Editing Summit

ViaCyte, Inc., an innovator in cellular therapy and regenerative medicine, announced today that Michael Yang, President & CEO, will present at the...

Oct 19, 2021, 08:00 ET ViaCyte to Participate in International Pancreas & Islet Transplantation Association Virtual Congress

Evert Kroon, Ph.D., Vice President of Translation Research at ViaCyte, Inc., an innovator in cellular therapy and regenerative medicine, will...

Oct 07, 2021, 08:00 ET ViaCyte to Present at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa

ViaCyte, Inc., an innovator in cellular therapy and regenerative medicine, announced today that it will present at the Alliance for Regenerative...

Sep 13, 2021, 08:00 ET ViaCyte Appoints Stem Cell Therapy Expert Dr. Timothy Kieffer as Chief Scientific Officer

ViaCyte, Inc., an innovator in cellular therapy and regenerative medicine, today announced the appointment of Timothy Kieffer, Ph.D., as Chief...

Jul 21, 2021, 08:00 ET ViaCyte Appoints Dr. Jon Wilensky as Head of Surgery

ViaCyte, Inc., an innovator in cellular therapy and regenerative medicine, announced today that it has appointed Jon Wilensky, MD, MBA, FACS, as Head ...

Jun 25, 2021, 11:30 ET ViaCyte Reports Compelling Preliminary Clinical Data from Islet Cell Replacement Therapy for Patients with Type 1 Diabetes

ViaCyte, Inc., a clinical-stage regenerative medicine company focused on developing cell therapies that provide a functional cure for patients with...

Jun 16, 2021, 08:00 ET ViaCyte to Present at the Raymond James 2021 Human Health Innovation Conference

ViaCyte, Inc., a clinical-stage regenerative medicine company focused on developing cell therapies that provide a functional cure for patients with...

Jun 09, 2021, 08:00 ET ViaCyte Announces Closing of $45 Million Financing to Advance Broadest Portfolio of Stem Cell-Derived Therapies for Type 1 Diabetes

ViaCyte, Inc., a clinical-stage regenerative medicine company, today announced the closing of a $45 million financing tranche that brings the total...

Jun 08, 2021, 07:00 ET ViaCyte Appoints Dr. Evert Kroon as Interim Chief Scientific Officer

ViaCyte, Inc., a clinical-stage regenerative medicine company focused on developing cell therapies that provide a functional cure for patients with...

Jun 01, 2021, 08:00 ET ViaCyte to Present Late-Breaking Data at the American Diabetes Association's 81st Scientific Sessions

ViaCyte, Inc., a clinical-stage regenerative medicine company focused on developing cell therapies that provide a functional cure for patients with...

May 26, 2021, 08:00 ET ViaCyte to Present at the Jefferies Virtual Healthcare Conference

ViaCyte, Inc., a clinical-stage regenerative medicine company focused on developing cell therapies that provide a functional cure for patients with...

May 11, 2021, 08:00 ET ViaCyte To Participate In World Medical Innovation Forum Panel On Future Of Cell Therapy For Type 1 Diabetes

Manasi Sinha Jaiman, M.D., M.P.H., Vice President, Clinical Development at ViaCyte, Inc., a clinical-stage regenerative medicine company, will...

Mar 02, 2021, 07:00 ET ViaCyte and Gore Expand Collaboration to Develop Novel Membrane and Device Technologies that Enhance Delivery of Cell Replacement Therapies for Diabetes

ViaCyte, Inc., a clinical stage regenerative medicine company, and W. L. Gore & Associates, Inc. ("Gore"), a leading global materials science company ...

Feb 03, 2021, 08:30 ET ViaCyte Announces Initiation of Phase 2 Study of Encapsulated Cell Therapy for Type 1 Diabetes Patients

ViaCyte, Inc., a clinical-stage regenerative medicine company, today announced that the first type 1 diabetes (T1D) patients have been implanted in a ...

Jan 27, 2021, 16:46 ET ViaCyte Appoints Michael Yang President and CEO and Provides Company Update

ViaCyte, Inc., a clinical-stage regenerative medicine company, today announced the appointment of Michael Yang to President and CEO and as a member...

Aug 13, 2020, 09:00 ET ViaCyte Appoints Dr. Manasi Sinha Jaiman as Vice President, Clinical Development

ViaCyte, Inc., a clinical stage regenerative medicine company, today announced the appointment of Manasi Sinha Jaiman, M.D., M.P.H. as Vice...

Aug 05, 2020, 09:00 ET ViaCyte and Gore Enter Clinical Phase Agreement Based on Novel Membrane Technology for PEC-Encap Product Candidate

ViaCyte, Inc., a clinical stage regenerative medicine company, and W. L. Gore & Associates, Inc. ("Gore"), a leading global materials science company ...

Jul 13, 2020, 09:00 ET ViaCyte Appoints Brittany Bradrick as Chief Financial Officer

ViaCyte, Inc., a clinical stage regenerative medicine company, today announced the appointment of Brittany Bradrick as Chief Financial Officer. Ms....

May 28, 2020, 09:00 ET ViaCyte to Present at the Jefferies Virtual Healthcare Conference

ViaCyte, Inc., a privately held regenerative medicine company, announced today that ViaCyte's President and CEO Paul Laikind, Ph.D. is scheduled to...

May 26, 2020, 09:00 ET ViaCyte Announces $27 Million Financing to Advance Next Generation Cell Therapies for Diabetes

ViaCyte, Inc., a privately held regenerative medicine company, today announced the close of an approximately $27 million private financing, part of...